Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3843363374 ISBN 13: 9783843363372
Da: Mispah books, Redhill, SURRE, Regno Unito
EUR 120,32
Quantità: 1 disponibili
Aggiungi al carrelloPaperback. Condizione: Like New. LIKE NEW. SHIPS FROM MULTIPLE LOCATIONS. book.
Lingua: Inglese
Editore: LAP LAMBERT Academic Publishing, 2012
ISBN 10: 3843363374 ISBN 13: 9783843363372
Da: moluna, Greven, Germania
EUR 41,67
Quantità: Più di 20 disponibili
Aggiungi al carrelloCondizione: New. Dieser Artikel ist ein Print on Demand Artikel und wird nach Ihrer Bestellung fuer Sie gedruckt. Autor/Autorin: Parmar RameshRamesh B. Parmar, Assistant Professor and Head of Pharmaceutics Department at S. J. Thakkar Pharmacy College, Rajkot. Completed my Ph. D. Work under the Guidance of Dr. H. M. Tank from Saurashtra University. I have Prese.
Lingua: Inglese
Editore: LAP Lambert Academic Publishing, 2012
ISBN 10: 3843363374 ISBN 13: 9783843363372
Da: AHA-BUCH GmbH, Einbeck, Germania
EUR 49,59
Quantità: 2 disponibili
Aggiungi al carrelloTaschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In recent years scientific and technological advances have been made in development of ocular controlled drug delivery system to overcome physiological adversities of conventional dosage form. The present investigation was focused to prepare resinate of moxifloxacin and ion exchange resign to increase the residence time and decrease the solubility of drug in ocular site and incorporated in ocular insert. Ocular insert was prepared by solvent casting method. Nine formulations of OCDDS were prepared with different concentration of polymer (HPMC, MC, and PVA). Prepared formulation was subjected to physicochemical evaluation test,In vitro release, In vivo release and accelerated stability study test. In vivo release of formulation BRF6 was shown 98.87 % at the end of 12th hrs. In vitro release of all the formulation was computed with release kinetic model to predict release rate.suggested that all formulation was followed anomalous diffusion mechanism. Optimized formulation (BRF6) was subjected to antimicrobial test and sterility test. Result clearly showed it was passed. Accelerated stability study indicated optimized formulation was stable for longer period of time.